Showing results (761-770 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of the American Heart Association|April 7, 2026
Assessing the Cost Effectiveness of an Incremental Lipid-Lowering Therapy Approach After Coronary Artery Bypass Grafting Using Nationwide DataSalil V Deo, Giorgio Ciminata, Gauranga Mahalwar, et al.BMC Medicine|April 4, 2023
Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participantsFanny Petermann-Rocha, Michael D Wirth, Jirapitcha Boonpor, et al.American Journal of Physiology. Heart and Circulatory Physiology|February 9, 2002
Direct effect of Pa(CO2) on respiratory sinus arrhythmia in conscious humansNobuko Sasano, Alex E Vesely, Junichiro Hayano, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 8, 2025
Diamond rotors for high magic angle spinning frequenciesLauren Schaffer, David Preiss, Ravi Shankar Palani, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 28, 2018
Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK BiobankClaire Welsh, Paul Welsh, Patrick B Mark, et al.Journal of the American College of Cardiology|September 24, 2021
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced TrialJames L Januzzi, Faiez Zannad, Stefan D Anker, et al.Circulation|November 15, 2021
Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O TrialCarolyn S P Lam, Chinthanie Ramasundarahettige, Kelley R H Branch, et al.European Journal of Heart Failure|November 15, 2023
Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR programJoão Pedro Ferreira, Milton Packer, Javed Butler, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 17, 2026
Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?Sabrina Scilletta, Maurizio Di Marco, Giosiana Bosco, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2011
Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at riskPaul Welsh, Heather M Murray, Ian Ford, et al.Pageof 129